Regeneron Pharmaceuticals, Inc.
Andrew J Murphy (Co-Chief Scientific Officer) sells REGN shares
AI-generated summary
Co-Chief Scientific Officer Andrew J Murphy exercised 17,000 options at an average price of $381.92, had 11,989 shares withheld for taxes at an average price of $960.02, and sold 5,011 shares at an average price of $957.76. After these transactions, the insider directly held 46,779 shares. The transactions were executed under a Rule 10b5-1 trading plan adopted on May 7, 2026.
Key facts
- Insider
- Andrew J Murphy · Co-Chief Scientific Officer
Rule 10b5-1 plan · adopted May 7, 2026
| Date | Transaction | Shares | Price | Value | Held after | Ownership |
|---|---|---|---|---|---|---|
| Nov 16, 2026 | M · exercise or conversion of a derivativeFootnotes F1 | +17,000 | $381.92 | $6,492,640.00 | 63,779 | Direct |
| Nov 16, 2026 | F · tax withholdingFootnotes F1 | −11,989 | $960.02 | $11,509,679.78 | 51,790 | Direct |
| Nov 17, 2026 | S · open-market saleFootnotes F1 | −93 | $949.69 | $88,321.17 | 51,697 | Direct |
| Nov 17, 2026 | S · open-market saleFootnotes F1, F2 | −74 | $950.61 | $70,345.14 | 51,623 | Direct |
| Nov 17, 2026 | S · open-market saleFootnotes F1, F3 | −298 | $951.75 | $283,621.50 | 51,325 | Direct |
| Nov 17, 2026 | S · open-market saleFootnotes F1, F4 | −220 | $952.75 | $209,605.00 | 51,105 | Direct |
| Nov 17, 2026 | S · open-market saleFootnotes F1, F5 | −671 | $953.69 | $639,925.99 | 50,434 | Direct |
| Nov 17, 2026 | S · open-market saleFootnotes F1, F6 | −313 | $954.45 | $298,742.85 | 50,121 | Direct |
| Nov 17, 2026 | S · open-market saleFootnotes F1, F7 | −313 | $955.48 | $299,065.24 | 49,808 | Direct |
| Nov 17, 2026 | S · open-market saleFootnotes F1, F8 | −346 | $956.70 | $331,018.20 | 49,462 | Direct |
| Nov 17, 2026 | S · open-market saleFootnotes F1, F9 | −202 | $957.53 | $193,421.06 | 49,260 | Direct |
| Nov 17, 2026 | S · open-market saleFootnotes F1, F10 | −244 | $958.27 | $233,817.88 | 49,016 | Direct |
| Nov 17, 2026 | S · open-market saleFootnotes F1, F11 | −506 | $959.45 | $485,481.70 | 48,510 | Direct |
| Nov 17, 2026 | S · open-market saleFootnotes F1, F12 | −257 | $960.65 | $246,887.05 | 48,253 | Direct |
| Nov 17, 2026 | S · open-market saleFootnotes F1, F13 | −584 | $961.45 | $561,486.80 | 47,669 | Direct |
| Nov 17, 2026 | S · open-market saleFootnotes F1, F14 | −295 | $962.70 | $283,996.50 | 47,374 | Direct |
| Nov 17, 2026 | S · open-market saleFootnotes F1, F15 | −255 | $963.60 | $245,718.00 | 47,119 | Direct |
| Nov 17, 2026 | S · open-market saleFootnotes F1, F16 | −340 | $964.36 | $327,882.40 | 46,779 | Direct |
| Nov 16, 2026 | M · exercise or conversion of a derivativeNon-Qualified Stock Option (right to buy)Footnotes F1, F17 | −17,000 | $0.00 | $0.00 | 0 | Direct |
Footnotes
- F1 Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c) adopted on May 7, 2026.
- F2 Represents volume-weighted average price of sales of 74 shares of Company stock on November 17, 2026 at prices ranging from $950.50 to $950.61. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 17, 2026 at each separate price.
- F3 Represents volume-weighted average price of sales of 298 shares of Company stock on November 17, 2026 at prices ranging from $951.41 to $951.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 17, 2026 at each separate price.
- F4 Represents volume-weighted average price of sales of 220 shares of Company stock on November 17, 2026 at prices ranging from $952.54 to $952.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 17, 2026 at each separate price.
- F5 Represents volume-weighted average price of sales of 671 shares of Company stock on November 17, 2026 at prices ranging from $953.18 to $953.94. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 17, 2026 at each separate price.
- F6 Represents volume-weighted average price of sales of 313 shares of Company stock on November 17, 2026 at prices ranging from $954.26 to $954.60. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 17, 2026 at each separate price.
- F7 Represents volume-weighted average price of sales of 313 shares of Company stock on November 17, 2026 at prices ranging from $955.02 to $955.68. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 17, 2026 at each separate price.
- F8 Represents volume-weighted average price of sales of 346 shares of Company stock on November 17, 2026 at prices ranging from $956.17 to $956.90. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 17, 2026 at each separate price
- F9 Represents volume-weighted average price of sales of 202 shares of Company stock on November 17, 2026 at prices ranging from $957.00 to $957.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 17, 2026 at each separate price.
- F10 Represents volume-weighted average price of sales of 244 shares of Company stock on November 17, 2026 at prices ranging from $958.12 to $958.44. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 17, 2026 at each separate price.
- F11 Represents volume-weighted average price of sales of 506 shares of Company stock on November 17, 2026 at prices ranging from $959.03 to $959.86. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 17, 2026 at each separate price.
- F12 Represents volume-weighted average price of sales of 257 shares of Company stock on November 17, 2026 at prices ranging from $960.10 to $960.96. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 17, 2026 at each separate price.
- F13 Represents volume-weighted average price of sales of 584 shares of Company stock on November 17, 2026 at prices ranging from $961.07 to $961.81. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 17, 2026 at each separate price.
- F14 Represents volume-weighted average price of sales of 295 shares of Company stock on November 17, 2026 at prices ranging from $962.17 to $962.91. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 17, 2026 at each separate price.
- F15 Represents volume-weighted average price of sales of 255 shares of Company stock on November 17, 2026 at prices ranging from $963.28 to $963.93. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 17, 2026 at each separate price.
- F16 Represents volume-weighted average price of sales of 340 shares of Company stock on November 17, 2026 at prices ranging from $964.03 to $964.73. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 17, 2026 at each separate price.
- F17 The stock option award vested in four equal annual installments, commencing one year after the date of grant.
More REGN filings
- S-8
Filed Nov 19, 2026
- 4
Filed Nov 18, 2026
- 4
Filed Nov 18, 2026
- 144
Filed Nov 17, 2026
- 144
Filed Nov 17, 2026
- 144
Filed Nov 16, 2026
Not investment advice. Summaries can contain errors; the SEC filing is the official record.